- $9.43bn
- $8.88bn
- $642.82m
U.S. RESEARCH ROUNDUP- Applied Materials, Humana, Gilead
10x Genomics Q4 revenue rises
Brief: Pharosai And 10X Genomics Partner To Transform Cancer Research With Ai And Spatial Biology
Brief: Cancer Research Institute Launches Transformative Ai-Driven Immuno-Oncology Initiative Powered By 10X Genomics Technology
10X Genomics Q4 prelim revenue beats on consumables unit strength
U.S. STOCKS ON THE MOVE-Akamai Technologies, Enbridge, KKR
U.S. STOCKS ON THE MOVE-Novo Nordisk, Block, Peloton Interactive
U.S. STOCKS ON THE MOVE-ANI Pharmaceuticals, Wendy's, nLIGHT
U.S. STOCKS ON THE MOVE-Tesla, gold and silver miners
10x Genomics jumps after forecasting Q4 revenue above estimates
U.S. RESEARCH ROUNDUP- Blackline, Carmax, Expedia
10X Genomics Q3 revenue beats expectations, net loss narrows
10x sues rival Illumina over gene-sequencing patents
Brief: 10X Genomics & Anthropic Partner To Make Single Cell & Spatial Analysis More Accessible
10X Genomics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: 10X Genomics Q2 Revenue USD 172.9 Million Vs. IBES Estimate USD 139.4 Million
Brief: All Ongoing Lawsuits Between Bruker And 10X Genomics To Be Withdrawn
U.S. RESEARCH ROUNDUP-Amphastar Pharmaceuticals, Comstock, Range Resources
10X Genomics Inc reports results for the quarter ended March 31 - Earnings Summary